Cart
sales@molnova.com
Denosumab
CAS No. 615258-40-7
Denosumab( —— )
Catalog No. M22148 CAS No. 615258-40-7
Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 510 | In Stock |
|
| 10MG | 736 | In Stock |
|
| 25MG | 1131 | In Stock |
|
| 50MG | 1479 | In Stock |
|
| 100MG | 2018 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDenosumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionDenosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
-
DescriptionDenosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number615258-40-7
-
Formula Weight147 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kuritani M, et al. Anti-mouse RANKL Antibodies Inhibit Alveolar Bone Destruction in Periodontitis Model Mice. Biol Pharm Bull.2018;41(4):637-643.
molnova catalog
related products
-
Kobusin
Kobusin, a Calmodulin inhibitor, shows mild antiplasmodial,anti-inflammatory, and cytotoxic activities; it may be beneficial for the treatment of neuro-inflammatory diseases through the inhibition of iNOS expression and peroxynitrite scavenging potential.
-
Notoginsenoside Ft1
Notoginsenoside Ft1 is a saponin originally isolated from P. notoginseng with diverse biological activities.
-
MARCKS PSD-Derived P...
MARCKS PSD-Derived Peptide, PKC Substrate
